First, although ERAP1+/− mice showed heightened colitis severity and altered immune cell profiles, the precise molecular mechanisms by which partial ERAP1 deficiency influences specific immune pathways (e.g., neutrophil activation, DC maturation, CD4+ T cell function) remain unclear. This evidence concerns the gene ERAP1 and colitis.